相关实验视频
Updated: Jun 25, 2025

10:07
Using Learning Outcome Measures to assess Doctoral Nursing Education
Published on: June 21, 2010
19.0K
评估美国PharmD课程中的课程差异:同行评价
M O Faruk Khan1, Mohamed Rashrash1, AlexiAnn Drouin1
1University of Charleston School of Pharmacy, Charleston, WV, USA.
American journal of pharmaceutical education
|May 23, 2024
概括
药学博士 (PharmD) 课程显示了重要的课程变化. 简化结构和内容可以提高灵活性,减少药房教育中的冗余.
科学领域:
- 药房教育 教育 药房教育
- 课程开发 课程开发
- 高等教育 高等教育
背景情况:
- 美国的药学博士 (PharmD) 课程具有多样化的课程结构和内容.
- 了解这些变化对于认证和计划改进至关重要.
研究的目的:
- 评估美国药学博士课程课程结构和内容的差异和共同点.
- 确定药房教育中潜在的标准化和增强的领域.
主要方法:
- 从135个认可的PharmD课程中收集和分析了课程数据 (课程内容,学分小时).
- 使用药学教育认证委员会 (ACPE) 准则进行分类.
- 评估的核心课程,选修课程和体验式教育组件.
主要成果:
- 观察到不同学科分配的学分小时的显著差异.
- 只有37个中只有9个ACP要求的内容领域在90%以上的学校被一致地分配了学分.
- 综合课程 (85所学校),三年制课程 (19所学校) 和远程学习 (15所学校) 是常见的结构变化.
结论:
- 在PharmD计划的学分小时分配和课程内容方面存在实质性的差异.
- 有机会简化课程,减少冗余和增加灵活性.
- 与不断变化的医疗保健需求调整课程对于有效的药学教育至关重要.
相关概念视频
Bioequivalence: Overview
1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Nursing Evaluation
3.3K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.3K
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Drug Administration and Therapy Phases: Overview
448
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
448

